Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke

Stroke

Volumn 30, Issue 12, 1999, Pages 2606-2611

  Carter, Angela M ^a   Catto, Andrew J ^a   Bamford, John M ^b   Grant, Peter J ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Mortality; Platelet glycoprotein GPIIb IIIa complex; Polymorphism (genetics); Stroke, ischemic

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR;

ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SURVIVAL RATE;

EID: 0032752066     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.12.2606     Document Type: Article

References (27)

1. Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien JR, Yamell JW. Ischemic heart disease and platelet aggregation: the Caerphilly Collaborative Heart Disease Study. Circulation. 1991;83:38-44.
2. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84:613-617.
3. Shah AB, Beamer N, Coull BM. Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke. 1985;16:643-647.
4. Uchiyama S, Takeuchi M, Osawa M, Kobayashi I, Maruyama S, Aosaki M, Hirosawa K. Platelet function tests in thrombotic cerebrovascular disorders. Stroke. 1983;14:511-517.
5. Konstantopoulos K, Grotta JC, Sills C, Wu KK, Heliums JD. Shearinduced platelet aggregation in normal subjects and stroke patients. Thromb Haemost. 1995;74:1329-1334.
6. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 1994;24:1591-1601.
7. Bennett JS. Structural biology of glycoprotein IIb-IIIa. TCM. 1996;6: 31-37.
8. Tcheng JE. Platelet glycoprotein IIb/IIIa integrin blockade: recent clinical trials in interventional cardiology. Thromb Haemost. 1997;78:205-209.
9. Bray PF, Barsh G, Rosa JP, Luo XY, Magenis E. Shuman MA. Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci U S A. 1988;85:8683-8687.
10. Nurden AT. Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance. Thromb Haemost. 1995;74:345-351.
11. A1/A2 polymorphism of platelet glycoprotein IIIa and risk of cardiovascular disease. Lancet. 1997;349:1100-1101.
12. 1A polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bβ 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation. 1997;96:1424-1431.
13. Walter DH, Schachinger V, Elsner M, Dimmeter S, Zeiner AM. Platelet glycoprotein IIIa polymorphism and risk of coronary stent thrombosis. Lancet. 1997;350:1217-1219.
14. A1/A2 polymorphism of platelet glyeoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 1997;349:385-388.
15. b alloantigen system. Blood. 1990;75:2343-2348.
16. Shadle PJ, Ginsberg MH, Plow EF, Barondes SH. Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb. J Cell Biol. 1984;99:2056-2060.
17. A and GPIb variable number tandem repeat (VNTR) polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vase biol. 1998;18:1124-1131.
18. Unkelbach K, Kalb R, Santoso S, Kroll H, Mueller-Eckhardt C, Kiefel V. Genomic RFLP typing of human platelet alloantigens Zw(PlA), Ko, Bak and Br (HPA-1, 2, 3, 5). Br J Haematol. 1995;89:169-176.
19. Carter AM, Catto AJ, Bamford JM, Gram PJ. Gender specific associations of the fibrinogen Bβ 448 polymorphism, fibrinogen levels and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol. 1997;17: 589-594.
20. Weir B, Cockerham C. Estimation of linkage disequilibrium in randomly mating populations. Heredity. 1979;42:105-111.
21. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity. 1974;1974:33:229-239.
22. Carter AM, Ossei-Gerning N, Grant PJ. Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction. Lancet. 1996; 348:485-486.
23. Sixma JJ, van Zanten GH, Saelman EU, Verkleij M, Lankhof H, Nieuwenhuis HK, de Groot PG. Platelet adhesion to collagen. Thromb Haemost. 1995;74:454-459.
24. Du X, Ginsberg MH. Integrin alpha Hb beta 3 and platelet function. Thromb Haemost. 1997;78:96-100.
25. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
26. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
27. Tunstall-Pedoe H, Woodward M. Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997;315:722-729.